Côd QR

Xanthine oxidase inhibitors treatment or discontinuation effects on mortality: evidence of xanthine oxidase inhibitors withdrawal syndrome

Objectives: This study investigates the impact of xanthine oxidase inhibitors (XOI) on mortality in patients with cardiovascular diseases. XOI withdrawal has been reported to increased mortality risk due to rapid adenosine triphosphate (ATP) deficiency. This study aims to determine whether XOI treat...

Disgrifiad llawn

Wedi'i Gadw mewn:
Prif Awduron: Masanari Kuwabara, Michikazu Nakai, Yoko Sumita, Yoshitaka Iwanaga, Ryusuke Ae, Takahide Kodama, Ichiro Hisatome, Naoyuki Kamatani
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Frontiers Media S.A. 2024-01-01
Cyfres:Frontiers in Pharmacology
Pynciau:
xanthine oxidase
xanthine oxidase inhibitors
mortality
withdrawal syndrome
epidemiology
uric acid
Mynediad Ar-lein:https://www.frontiersin.org/articles/10.3389/fphar.2023.1289386/full
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg